Contemporary Perspectives on the Role of Vitamin D in Enhancing Gut Health and Its Implications for Preventing and Managing Intestinal Diseases.
Study Goal
The researchers aimed to explore the mechanistic role of Vitamin D in modulating gut microbiome composition and intestinal barrier function, as well as its therapeutic potential in managing intestinal diseases.
Results Summary
The study found that Vitamin D deficiency alters gut microbiome composition, compromises intestinal mucosal barrier integrity, and is linked to intestinal pathologies like inflammatory bowel disease. Vitamin D regulates immune responses via VDR binding, influencing cytokine production and barrier function.
Population
Patients with intestinal diseases (e.g., inflammatory bowel disease, irritable bowel syndrome, celiac disease) and general gut health.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Vitamin D | decrease | gut microbiome composition | individuals | - | implicated in altering | #1 |
Vitamin D | decrease | integrity of the intestinal mucosal barrier | individuals | - | compromising | #2 |
Vitamin D | increase | various intestinal pathologies | individuals | - | predisposing | #3 |
Vitamin D | decrease | production of pro-inflammatory cytokines | - | - | modulating | #4 |
Vitamin D | neutral | intestinal barrier function | - | - | influencing | #5 |
Vitamin D | decrease | serum vitamin D levels | patients suffering from intestinal diseases, including inflammatory bowel disease, irritable bowel syndrome, and celiac disease | - | lower | #6 |
Vitamin D, a crucial fat-soluble vitamin, is primarily synthesized in the skin upon exposure to ultraviolet radiation and is widely recognized as a bone-associated hormone. However, recent scientific advancements have unveiled its intricate association with gut health. The intestinal barrier serves as a vital component, safeguarding the intestinal milieu and maintaining overall homeostasis. Deficiencies in vitamin D have been implicated in altering the gut microbiome composition, compromising the integrity of the intestinal mucosal barrier, and predisposing individuals to various intestinal pathologies. Vitamin D exerts its regulatory function by binding to vitamin D receptors (VDR) present in immune cells, thereby modulating the production of pro-inflammatory cytokines and influencing the intestinal barrier function. Notably, numerous studies have reported lower serum vitamin D levels among patients suffering from intestinal diseases, including inflammatory bowel disease, irritable bowel syndrome, and celiac disease, highlighting the growing significance of vitamin D in gut health maintenance. This comprehensive review delves into the latest advancements in understanding the mechanistic role of vitamin D in modulating the gut microbiome and intestinal barrier function, emphasizing its pivotal role in immune regulation. Furthermore, we consolidate and present relevant findings pertaining to the therapeutic potential of vitamin D in the management of intestinal diseases.